Skip to main content
SpringerLink
Log in

Effects of the Committee on Safety of Medicines Advice on Antidepressant Prescribing to Children and Adolescents in the UK

  • Correspondence
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Murray ML, Thompson M, Santosh PJ, et al. Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK. Drug Saf 2005; 28(12): 1151–7

    Article  PubMed  CAS  Google Scholar 

  2. Department of Health. Child and Adolescent Mental Health Service Mapping 2004/05. [online]. Available from URL: www.dur.ac.uk/camhs.mapping/ [Accessed 2006 May 3]

  3. Gledhill J, Kramer T, Iliffe S, et al. Training general practitioners in the identification and management of adolescent depression within the consultation: a feasibility study. J Adolesc 2003; 26: 245–50

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors have no conflicts of interest that are directly relevant to the content of this letter.

Author information

Authors and Affiliations

  1. Child and Adolescent Mental Health Service, Lincoln, UK

    Anne Thompson, Saeed Nazir & Walid Sorour

Authors
  1. Anne Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Saeed Nazir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Walid Sorour
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thompson, A., Nazir, S. & Sorour, W. Effects of the Committee on Safety of Medicines Advice on Antidepressant Prescribing to Children and Adolescents in the UK. Drug-Safety 29, 549 (2006). https://doi.org/10.2165/00002018-200629060-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200629060-00007

Keywords

Search

Navigation